Evaluation of Cost of Managing Hepatitis C In Greece Across All Disease Stages and The Potential Value of Simeprevir Triple Regimen As A Treatment Option In The Early Stages
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2198
https://www.valueinhealthjournal.com/article/S1098-3015(15)04274-6/fulltext
Title :
Evaluation of Cost of Managing Hepatitis C In Greece Across All Disease Stages and The Potential Value of Simeprevir Triple Regimen As A Treatment Option In The Early Stages
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04274-6&doi=10.1016/j.jval.2015.09.2198
First page :
A625
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1612